JCR Pharmaceuticals Co., Ltd. (OTCMKTS:JCRRF – Get Free Report) was the recipient of a significant decrease in short interest in August. As of August 31st, there was short interest totaling 238,313 shares, a decrease of 48.0% from the August 15th total of 457,885 shares. Based on an average daily trading volume, of 27 shares, the short-interest ratio is currently 8,826.4 days.
JCR Pharmaceuticals Price Performance
Shares of OTCMKTS:JCRRF remained flat at $3.33 during midday trading on Wednesday. The stock’s 50-day simple moving average is $3.32 and its 200-day simple moving average is $3.68. JCR Pharmaceuticals has a 52 week low of $3.15 and a 52 week high of $3.33.
JCR Pharmaceuticals Company Profile
JCR Pharmaceuticals Co, Ltd. is a Japan-based biotechnology company specializing in the development, production and commercialization of plasma-derived products and regenerative medicine solutions. The company focuses on manufacturing high-purity plasma proteins, including human serum albumin, immunoglobulins and coagulation factors, to support a range of therapeutic applications in hematology, immunology and critical care settings.
In its plasma-derived business, JCR leverages state-of-the-art fractionation and purification processes to supply products such as intravenous immunoglobulin and albumin formulations.
See Also
- Five stocks we like better than JCR Pharmaceuticals
- AI Panic Hit Tech Stocks—But NVIDIA’s Growth Engine Is Intact
- 5 Buy-and-Hold Stocks Built to Weather a Volatile Market
- Movado’s Turnaround Gains Momentum
- Qualcomm’s Discount Could Vanish If Its AI Bet Pays Off
Receive News & Ratings for JCR Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for JCR Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
